Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools


You are here: Home
20 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Parise and Leisner research into protein CIB1 profiled in Raleigh News and Observer
by William Shawn Davis published Oct 29, 2012 — filed under: ,
The Raleigh News and Observer interviewed Leslie Parise, PhD, professor and chair of the department of biochemistry, and Tina Leisner, PhD, a UNC research associate in biochemistry, about their research into the linkage between breast cancer and the protein CIB1.
Located in News / 2012 News
Amos discusses breast cancer in the black community on Black Issues Forum
by William Shawn Davis published Oct 29, 2012 last modified Oct 29, 2012 09:20 AM — filed under: ,
Keith Amos, MD, FACS, was interviewed by UNC-TV’s Black Issues Forum on community education about breast cancer in the African American community on Sunday, Oct. 28.
Located in News / 2012 News
UNC Lineberger scientists lead cancer genome analysis of breast cancer
by Mary Ruth published Sep 24, 2012 last modified Oct 05, 2012 11:28 AM — filed under: , ,
Team identifies genetic causes and similarity to ovarian cancer
Located in News / 2012 News
Amos quoted in ABC News feature
by Mary Ruth published Jul 13, 2012 last modified Jul 13, 2012 10:55 AM — filed under: , ,
Keith Amos, MD, assistant professor of surgery at UNC-Chapel Hill, is quoted in an ABC News feature discussing a new study about partial breast removal surgery to treat cancer.
Located in News / 2012 News
Exercise, even mild physical activity, may reduce breast cancer risk
by Mary Ruth published Jun 25, 2012 last modified Jun 25, 2012 03:31 PM — filed under: , ,
A new analysis done by University of North Carolina at Chapel Hill researchers has found that physical activity - either mild or intense and before or after menopause - may reduce breast cancer risk, but substantial weight gain may negate these benefits.
Located in News / 2012 News
Dr. Lisa Carey authors editorial on neoadjuvant trials for breast cancer
by Mary Ruth published Jun 15, 2012 last modified Jun 22, 2012 02:45 PM — filed under: , ,
Lisa Carey, MD, authored an editorial, titled “Neoadjuvant Trials of Human Epidermal Growth Factor Receptor 2 Targeting: How Many Drugs Do We Need?”
Located in News / 2012 News
Combination therapy for triple-negative breast cancer disappointing
by Mary Ruth published Jun 12, 2012 last modified Jun 12, 2012 09:31 AM — filed under: , ,
CHAPEL HILL, N.C. – A recent clinical trial testing a combination therapy for basal-like (also known as triple-negative) breast cancer demonstrates that a combination of two drugs with promising preclinical results is not as effective as researchers had hoped.
Located in News / 2012 News
Grant to fund use of kinase test in HER2-positive breast cancer
by Mary Ruth published May 14, 2012 last modified May 15, 2012 03:49 PM — filed under: , ,
Chapel Hill, NC – Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.
Located in News / 2012 News
UNC scientists publish results from breast cancer survivors wellness workshops
by Mary Ruth published Feb 02, 2012 last modified Mar 06, 2013 08:57 AM — filed under: , ,
Scientists from UNC Lineberger have published a report describing an outreach program they developed for breast cancer survivors in four NC counties.
Located in News / 2012 News
UNC radiation oncologists co-author Journal of Clinical Oncology editorial on breast cancer radiotherapy and coronary artery stenosis
by Mary Ruth published Jan 11, 2012 last modified Jan 11, 2012 01:03 PM — filed under: , ,
Timothy Zagar, MD, assistant professor of radiation oncology, and Lawrence Marks, MD, professor and chair of radiation oncology, co-authored an editorial in the December 27, 2011 issue of the Journal of Clinical Oncology.
Located in News / 2012 News